Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results Nov 1, 2018
Viveve Submits Investigational Device Exemption to FDA to Conduct LIBERATE-U.S. Trial for Improvement of Stress Urinary Incontinence Sep 11, 2018
